As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots against the deadly mosquito-borne disease.
Dengue, which causes severe flu-like symptoms and debilitating body aches, has exploded globally, fuelled by rising
temperatures and densely populated cities.
The World Health Organization (WHO) says that almost half the world's population is now at risk, with 100-400 million infections every year.
India alone has recorded over one million cases and at least 1,500 deaths since 2021.